North American Vaccine Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : North American Vaccine

NVX 1.245

+2.9%

12:24 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Don W Stone who wrote (358)	5/11/1998 11:53:00 PM
From: Cacaito	Read Replies (2) of 507

Don, What are the chances that other companies will quickly follow NVX strategy: MONOCOMPONENT toxoid vaccine? Is NVX protected by any patent? At least some protection is conferred by the fact that others will have to developed and proof their products to the FDA, this affords time protection. This could be several long years in favor of NVX.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next